Less-common depression treatments, including transcranial magnetic stimulation, ketamine, and esketamine, can boost the effectiveness of antidepressant medications.

Combat veterans fight for recognition and care, while a new drug emerges as a possible solution for PTSD.

Esketamine is associated with a 7-point reduction in symptoms of treatment-resistant depression at week 1, with nearly 50% of patients responding by week 4, in new research.

Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported ...

Researchers have found that the post-traumatic stress disorder (PTSD) rate for correctional officers is higher than for the military or police officers. A primary reason is correctional officers work ...

What is Deep Brain Stimulation for depression? Discover how the TRANSCEND trial at UT Southwestern is using "brain pacemakers" to treat treatment-resistant depression by targeting neural communication ...

EBGLYSS (lebrikizumab-lbkz) delivered durable skin clearance and relief from persistent itch for up to four years for ...

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression ...

Many therapists recognize dissociation but feel unsure how to treat it. When dissociation is present, standard trauma ...

RESEDA, CA - March 20, 2026 - PRESSADVANTAGE - Moment of Clarity has released a detailed educational resource outlining ...

This post is Part 1 of 3. “I treat trauma, but I don’t treat DID.” As a psychologist who has spent more than two decades working with complex trauma and dissociation, I hear this sentence more often ...